UNITED STATES
                 SECURITIES AND EXCHANGE COMMISSION
                       Washington, D.C. 20549
                             FORM 10-QSB

(Mark One)

[X]                 QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d)
                    OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended: September 30, 2003

Or

[ ]                TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d)
                   OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from ____________ to _____________

Commission File Number: 000-33187

                        CareDecision Corporation
                        ------------------------
         (Exact name of registrant as specified in its charter)

                  Nevada                         91-2105842
                  ------                         ----------
     (State or other jurisdiction of          (I.R.S. Employer
      incorporation or organization)         Identification No.)

2660 Townsgate Road, Westlake Village, Suite 300, CA      91361
----------------------------------------------------      -----
     (Address of principal executive offices)           (Zip Code)

                           (805) 446-1973
                           --------------
        (Registrant's telephone number, including area code)

  2 Penn Plaza, 15th Floor, Suite 1500-53, New York, NY, 10121
  ------------------------------------------------------------
       (Former name, former address and former fiscal year,
                  if changed since last report)

 Indicate by check mark whether the registrant (1) has filed all
   reports required to be filed by Section 13 or 15(d) of the
 Securities Exchange Act of 1934 during the preceding 12 months
 (or for such shorter period that the registrant was required to
   file such reports), and (2) has been subject to such filing
               requirements for the past 90 days.
                         Yes [X] No [ ]

  APPLICABLE ONLY TO ISSUERS INVOLVED IN BANKRUPTCY PROCEEDINGS
                DURING THE PRECEDING FIVE YEARS:
   Indicate by check mark whether the registrant has filed all
documents and reports required to be filed by Sections 12, 13 or
 15(d) of the Securities Exchange Act of 1934 subsequent to the
  distribution of securities under a plan confirmed by a court.
                         Yes [ ] No [ ]

              APPLICABLE ONLY TO CORPORATE ISSUERS:
The number of shares outstanding of each of the issuer's classes
     of common stock as of the most recent practicable date:
                           113,784,921


/1/


                           CareDecision Corporation
                       [formerly ATR Search Corporation]
                         (a Development Stage Company)


                               Table of Contents

                                                                          Page

PART I - FINANCIAL INFORMATION

  Item 1. Financial Statements                                              3

     Consolidated Balance Sheet September 30, 2003 (unaudited)              4

     Consolidated Statements of Operations For the Three and Nine Months    5
     Ended September 30, 2003 and 2002 (unaudited) and For the Period
     July 6, 2000 (Inception) to September 30, 2003 (unaudited)

     Consolidated Statements of Cash Flows For the Nine Months Ended        6
     September 30, 2003 and 2002 (unaudited) and For the Period
     July 6, 2000 (Inception) to September 30, 2003 (unaudited)

     Notes to Financial Statements                                          7

  Item 2. Management's Discussion and Plan of Operation                    11

PART II - OTHER INFORMATION

  Item 1. Legal Proceedings                                                15

  Item 6(a). Exhibits                                                      15

  Item 6(b). Reports Filed on Form 8-K                                     16

SIGNATURES                                                                 17


/2/


Part I - Financial Information

     Item 1. Financial Statements






                    CareDecision Corporation
                [formerly ATR Search Corporation]
                  (a Development Stage Company)

                   Consolidated Balance Sheet
                              as of
                 September 30, 2003 (unaudited)

                               and

              Consolidated Statements of Operations
               for the Three and Nine Months Ended
            September 30, 2003 and 2002 (unaudited),
                       and For the Period
   July 6, 2000 (Inception) to September 30, 2003 (unaudited)

                               and

              Consolidated Statements of Cash Flows
                    for the Nine Months Ended
            September 30, 2003 and 2002 (unaudited),
                       and For the Period
   July 6, 2000 (Inception) to September 30, 2003 (unaudited)


/3/


                           CareDecision Corporation
                       [formerly ATR Search Corporation]
                         (a Development Stage Company)
                          Consolidated Balance Sheet
                                  (unaudited)


                                                              September 30,
  Assets                                                           2003
                                                              -------------
  Current assets:
     Cash and equivalents                                     $      44,347
     Accounts receivable, net of allowance for
      doubtful accounts of $12,500                                   21,748
                                                              -------------
          Total current assets                                       66,095
                                                              -------------

  Fixed assets, net                                               1,238,763
                                                              -------------

                                                              $   1,304,858
                                                              =============

  Liabilities and Stockholders' Equity

  Current liabilities:
     Note payable to shareholder                              $      91,078
     Stock subscription payable                                      13,750
     Notes payable                                                  513,527
                                                              -------------
          Total current liabilities                                 618,355
                                                              -------------

                                                                    618,355
                                                              -------------

  Stockholders' equity:
     Preferred stock, $0.001 par value, 5,000,000 shares
      authorized, no shares issued and outstanding                        -
     Common stock, $0.001 par value, 200,000,000 shares
      authorized, 113,784,921 shares issued and outstanding         113,785
     Additional paid-in capital                                   3,941,402
     Treasury stock                                                 (96,750)
     (Deficit) accumulated during development stage              (3,271,934)
                                                              -------------
                                                                    686,503
                                                              -------------

                                                              $   1,304,858
                                                              =============



 The accompanying notes are an integral part of these financial statements.


/4/


                           CareDecision Corporation
                       [formerly ATR Search Corporation]
                         (a Development Stage Company)
                     Consolidated Statements of Operations
                                  (unaudited)


                         For the                  For the
                       three months             nine months       July 6, 2000
                    ended September 30,     ended September 30,  (Inception) to
                    --------------------   ---------------------- September 30,
                       2003       2002        2003         2002        2003
                    ---------  ---------  -----------  -----------  -----------
                               (Restated)               (Restated)  (Restated)

Revenue             $  22,848  $     500  $    24,698  $     1,555  $   26,698
                    ---------  ---------  -----------  -----------  ----------

Expenses:
 General and admini-
  strative expenses    35,556    159,028      119,545      751,323     202,231
 Payroll expense       48,415          -      171,209            -     358,028
 Professional fees     11,465          -       54,693            -     226,545
 Consulting expense   152,750    276,056      508,750      276,056   1,828,232
 Software development       -          -        3,950            -     132,950
 Depreciation          80,622     80,383      246,274       80,383     407,040
                    ---------  ---------  -----------  -----------  ----------
   Total expenses     328,808    515,467    1,104,421    1,107,762   3,155,026
                    ---------  ---------  -----------  -----------  ----------

Other income (expenses):
 (Loss) on debt
  settlement          (25,000)   (68,363)     (62,094)     (68,363)    (88,019)
 Interest income            -      1,885          561        2,852       2,791
 Interest (expenses)  (12,754)   (14,399)     (35,558)     (22,650)    (58,378)
                    ---------  ---------  -----------  -----------  ----------
Net (loss)          $(343,714) $(595,844) $(1,176,814) $(1,194,368)$(3,271,934)

Weighted average
number of
common shares
outstanding -
basic and fully
diluted           100,990,475 21,027,802   92,711,681   33,279,930
                  =========== ==========   ==========   ==========

Net (loss)
per share -
basic and fully
diluted             $   (0.00) $   (0.03) $     (0.01) $     (0.04)
                    =========  =========  ===========  ===========



 The accompanying notes are an integral part of these financial statements.


/5/


                           CareDecision Corporation
                       [formerly ATR Search Corporation]
                         (a Development Stage Company)
                     Consolidated Statements of Cash Flows
                                  (unaudited)


                                 For the nine months ended     July 6,2000
                                       September 30,         (inception) to
                                --------------------------    September 30,
                                    2003          2002            2003
                                ------------  ------------   --------------
                                               (Restated)      (Restated)

Cash flows from operating
 activities
Net (loss)                      $ (1,176,814) $ (1,194,368)  $   (3,271,934)
Shares issued for services           508,750       276,056        1,828,232
Loss on debt settlement               62,094        68,363           88,019
Depreciation                         246,274        80,383          407,040
Adjustments to reconcile net
 (loss) to net cash (used) by
 operating activities:
  Decrease in accounts receivable      5,376             -                -
  (Increase) in notes receivable     (34,248)      (15,850)         (21,748)
                                ------------  ------------   --------------
Net cash (used) by operating
 activities                         (388,568)     (785,416)        (970,391)
                                ------------  ------------   --------------

Cash flows from financing
 activities
  Proceeds from convertible
   notes - related party              50,000             -           50,000
  Proceeds from notes payable         25,000       485,418          513,527
  Payments on notes payable           (1,890)            -          (37,493)
  Accrued interest                     3,095             -            3,095
  Proceeds from note payable
   to shareholder                    130,606             -          130,606
  Payments on note payable
   to shareholder                    (20,347)            -          (20,347)
  Stock subscription payable          13,750             -           13,750
  Issuance of common stock           121,600       649,801          361,600
                                ------------  ------------   --------------
Net cash provided by financing
 activities                          321,814     1,135,219        1,014,738
                                ------------  ------------   --------------

Net increase in cash                 (66,754)      349,803           44,347
Cash - beginning                     111,101             4                -
                                ------------  ------------   --------------
Cash - ending                   $     44,347  $    349,807   $       44,347
                                ============  ============   ==============

Supplemental disclosures:
  Interest paid                 $          -  $          -   $            -
                                ============  ============   ==============
  Income taxes paid             $          -  $          -   $            -
                                ============  ============   ==============

Non-cash transactions:
Number of shares issued for
services provided                 26,309,748       276,056       45,927,485
                                ============  ============   ==============

Number of shares issued to
acquire technology                 2,500,000             -        2,500,000
                                ============  ============   ==============

Number of shares issued for
debt settlement                      741,875             -          741,875
                                ============  ============   ==============



 The accompanying notes are an integral part of these financial statements.


/6/


                    CareDecision Corporation
                [formerly ATR Search Corporation]
                  (a Development Stage Company)
                              Notes

Note 1 - Basis of presentation

The  consolidated  interim financial statements included  herein,
presented  in  accordance with United States  generally  accepted
accounting  principles  and  stated  in  US  dollars,  have  been
prepared by the Company, without audit, pursuant to the rules and
regulations  of the Securities and Exchange Commission.   Certain
information   and  footnote  disclosures  normally  included   in
financial   statements  prepared  in  accordance  with  generally
accepted  accounting  principles have been condensed  or  omitted
pursuant  to  such  rules and regulations, although  the  Company
believes   that  the  disclosures  are  adequate  to   make   the
information presented not misleading.

These  statements reflect all adjustments, consisting  of  normal
recurring  adjustments, which, in the opinion of management,  are
necessary  for  fair  presentation of the  information  contained
therein.   It  is  suggested  that  these  consolidated   interim
financial statements be read in conjunction with the consolidated
financial statements of the Company for the period ended December
31, 2002 and notes thereto included in the Company's Form 10-KSB.
The   Company  follows  the  same  accounting  policies  in   the
preparation of consolidated interim reports.

Results  of operations for the interim periods are not indicative
of annual results.

Note 2 - Going concern

The accompanying financial statements have been prepared assuming
that  the  Company  will  continue  as  a  going  concern,  which
contemplates the recoverability of assets and the satisfaction of
liabilities in the normal course of business. As noted above, the
Company is in the development stage and, accordingly, has not yet
generated  a  proven history of operations. Since its  inception,
the   Company   has  been  engaged  substantially  in   financing
activities and developing its product line, incurring substantial
costs and expenses. As a result, the Company incurred accumulated
net losses from July 6, 2000 (inception) through the period ended
September  30,  2003  of $3,271,934. In addition,  the  Company's
development  activities  since inception  have  been  financially
sustained by capital contributions.

The  ability  of  the Company to continue as a going  concern  is
dependent upon its ability to raise additional capital  from  the
sale  of  common  stock  and,  ultimately,  the  achievement   of
significant   operating   results.  The  accompanying   financial
statements do not include any adjustments that might be  required
should  the Company be unable to recover the value of its  assets
or satisfy its liabilities.

Note 3 - Change in accounting principle

The  Company  determined during the nine months ending  September
30,  2003  that it is appropriate to reclassify software acquired
in  2002 from intellectual property to fixed assets.  The  effect
of  the change in accounting principle requires a restatement  of
the December 31, 2002, and March 31, 2003 financial statements in
order  to  properly  reflect the asset reclassification  and  the
related  adjustment to depreciation expense.  The effect of  this
change was to decrease net income for the year ended December 31,
2002  and  the three months ended March 31, 2003 by $119,988  and
$63,409, respectively.  Retained earnings as of January  1,  2002
has  been adjusted for the retroactive application of the  change
in accounting principle.

Note 4 - Fixed assets

On   February  5,  2003,  the  Company  acquired  fully-developed
software  valued  at  $181,250 from CareDecision.net,  Inc.,  the
former  parent corporation of Medicius, Inc.  Medicius, Inc.  was
acquired  by  the Company in June 2002. Several  of  the  control
persons  from CareDecision.net, Inc. are in similar positions  of
control at the Company.

Depreciation  expense totaled $246,274 for the nine-month  period
ended September 30, 2003.


/7/


                    CareDecision Corporation
                [formerly ATR Search Corporation]
                  (a Development Stage Company)
                              Notes

Note 5 - Notes payable - related party

During  the  nine  months ended September 30, 2003,  the  Company
received  loans totaling $130,606 from a Company shareholder  and
director.   The notes bear interest at 9% per annum and  are  due
365 days from date of issuance.

During  the  nine  months ended September 30, 2003,  the  Company
recorded interest expense of $35,558.

Note 6 - Convertible notes

During  the  nine  months ended September 30, 2003,  the  Company
received a loan totaling $50,000 from a Company shareholder.  The
note is convertible into 1,538,500 shares of the Company's $0.001
par  value  common stock at a strike price of $0.0325 per  share.
The  convertible  note  also carried with it  1,538,500  warrants
exercisable on a one-for-one basis at a strike price  of  $0.0325
per  share.  On April 22, 2003, the holder elected to convert the
note  into  1,538,500 shares of the Company's  $0.001  par  value
common stock.

Note 7 - Stockholder's equity

During  the  nine  months ended September 30, 2003,  the  Company
issued  8,000,000  shares of $0.001 par  value  common  stock  to
various individuals for consulting services valued at $356,000.

During  the  nine  months ended September 30, 2003,  the  Company
issued  2,500,000  shares of $0.001 par  value  common  stock  to
acquire    developed   software   valued   at    $181,250    from
CareDecision.net, Inc.

During  the  nine  months ended September 30, 2003,  the  Company
issued 741,875 shares of its $0.001 par value common stock to  an
individual as settlement for past debts valued at $37,094.

On  July 21, 2003, the Company issued an 8% share dividend to its
shareholders of record.  The Company issued 6,469,132  shares  of
its  $0.001  par  value  common stock pursuant  to  the  dividend
issuance.

On  July 1, 2003, the Company entered into a consulting agreement
with   Anthony  Quintiliana  to  perform  information  technology
services  for the Company.  As consideration, the Company  issued
1,500,000  shares of $0.001 par value common stock on August  18,
2003,  and  stock  options  to purchase an  additional  2,000,000
shares  of  $0.001 par value common stock at a  strike  price  of
$0.05 per share pursuant to the Company's 2003 Stock Option Plan.
The shares will be registered and free-trading via Form S-8.   On
September  18,  2003, Mr. Quintiliana exercised his  options  and
purchased 2,000,000 shares of stock for cash totaling $101,600.

On  July 1, 2003, the Company entered into a consulting agreement
with  Barbara  Asbell  to perform medical information  technology
services  for the Company.  As consideration, the Company  issued
2,500,000  shares of $0.001 par value common stock.   The  shares
will be registered and free-trading via Form S-8.  Based upon the
terms  of  her  consulting agreements, Ms. Asbell has  agreed  to
rescind  an  equal  number  of  her  existing  shares  bearing  a
restricted legend.

On July 15, 2003, the Company entered into a consulting agreement
with  Leslie-Michelle Abraham to perform corporate administrative
services  for the Company.  As consideration, the Company  issued
stock  options  to  purchase 850,000 shares of $0.001  par  value
common stock at a strike price of $0.05 per share pursuant to the
Company's  2003 Stock Option Plan.  The shares will be registered
and  free-trading  via  Form S-8.  On  September  30,  2003,  Ms.
Abraham exercised her options and acquired 850,000 shares of  the
Company's  $0.001  par value common stock for cash  and  services
totaling $42,500.


/8/


                    CareDecision Corporation
                [formerly ATR Search Corporation]
                  (a Development Stage Company)
                              Notes

On  August  18,  2003, the Company issued 300,000 shares  of  its
$0.001  par  value  common stock to its  employees  for  services
valued at $20,833.

On  September 12, 2003, the Company issued 15,059,748  shares  of
its  $0.001  par  value common stock to various  individuals  and
entities for past services valued at $644,001.  The services have
been   previously  expensed  and  accrued  for  by  the   Company
throughout the year ended December 31, 2002, and during the  nine
months ended September 30, 2003.

There have been no other issuances of preferred or common stock.

Note 8 - Related party transactions

During  the  nine  months ended September 30, 2003,  the  Company
acquired fully-developed software from CareDecision.net,  Inc,  a
private  corporation  with  several control  persons  serving  in
similar positions at the Company.  Pursuant to the agreement, the
Company  paid  CareDecision.net, Inc. the sum  of  $181,250  with
2,500,000 shares of the Company's $0.001 par value common stock.

During  the  nine  months ended September 30, 2003,  the  Company
received  $100,150  from  Robert Cox, a Company  shareholder  and
Chairman  of  the  Board.  The notes are due  on  365  days  from
issuance and accrued interest at 9% per annum.

During  the  nine  months ended September 30, 2003,  the  Company
received $50,000 from Dr. Thomas Chillemi, a Company shareholder,
the  note  is convertible into 1,538,500 shares of the  Company's
$0.001  par  value  common stock and carries  with  it  1,538,500
warrants exercisable on a one-for-one basis at a strike price  at
$0.0325  per share. On April 22, 2003 Dr. Chillemi exercised  the
convertible  portion of his note and converted the  $50,000  debt
into  1,538,500  shares of the Company's $.001 par  value  common
stock.

On July 10, 2003, the Company entered into a consulting agreement
with  Dr.  Thomas  Chillemi, a Company  shareholder,  to  perform
corporate    development   services   for   the   Company.     As
consideration,  the  Company issued  stock  options  to  purchase
3,000,000  shares of $0.001 par value common stock  at  a  strike
price  of  $0.05 per share pursuant to the Company's  2003  Stock
Option Plan.  The shares will be registered and free-trading  via
Form S-8.

On July 15, 2003, the Company entered into a consulting agreement
with Dr. Joseph A. Wolf, a Company shareholder to perform medical
information   technology   services   for   the   Company.     As
consideration,  the  Company issued  stock  options  to  purchase
950,000 shares of $0.001 par value common stock at a strike price
of  $0.05  per share pursuant to the Company's 2003 Stock  Option
Plan.  The shares will be registered and free-trading via Form S-
8.

Note 9 - Stock option plan

On  January  1, 2003, the Company adopted its "2003 Stock  Option
Plan"  (the "Plan") and granted incentive and nonqualified  stock
options  with  rights  to  purchase  25,000,000  shares  of   the
Company's  $0.001  par value common stock.   The  Company  issued
13,500,000 shares of stock pursuant to the plan during  the  nine
months ended September 30, 2003.

On  August  5,  2003,  the  Company  entered  into  a  consulting
agreement  with  Ely Mandell to perform corporate  strategic  and
developmental  services for the Company.  As  consideration,  the
Company issued stock options to purchase 150,000 shares of $0.001
par  value  common  stock at a strike price of  $0.05  per  share
pursuant  to  the Company's 2003 Stock Option Plan.   The  shares
will be registered and free-trading via Form S-8.


/9/


                    CareDecision Corporation
                [formerly ATR Search Corporation]
                  (a Development Stage Company)
                              Notes

Note 10 - Subsequent events

On  October 31, 2003 Dr. Wolf exercised all 950,000 of his  stock
options by rendering $47,500.00 in cash.

On  October 1, 2003 Dr. Chillemi exercised 1,000,000 of his stock
options  as  consideration  for  services  performed  valued   at
$50,000.   On  November  1,  2003,  Dr.  Chillemi  exercised   an
additional  1,000,000 of his stock options as  consideration  for
services performed valued at $50,000.

Note  11  -  Reverse acquisitions agreement with  Medicius,  Inc.
(MED)

On  June 21, 2002, the Company entered into an agreement with MED
whereby  the  Company acquired all of the issued and  outstanding
common  stock of NDI in exchange for 38,043,863 voting shares  of
the Company's $0.001 par value common stock.  The acquisition was
accounted  for  using  the  purchase  method  of  accounting   as
applicable   to   reverse   acquisitions   because   the   former
stockholders  of  the MED controlled the Company's  common  stock
immediately  upon conclusion of the transaction.   Under  reverse
acquisition accounting, the post-acquisition entity was accounted
for  as  a recapitalization of MED.  The common stock issued  was
recorded  at $0, being the fair value of the Company's assets  on
the acquisition date.


/10/


     Item 2. Management's Discussion and Plan of Operation

Forward-Looking Statements

     This Quarterly Report contains forward-looking statements
about our business, financial condition and prospects that
reflect our assumptions and beliefs based on information
currently available.  We can give no assurance that the
expectations indicated by such forward-looking statements will be
realized.  If any of our assumptions should prove incorrect, or
if any of the risks and uncertainties underlying such
expectations should materialize, our actual results may differ
materially from those indicated by the forward-looking
statements.

     The key factors that are not within our control and that may
have a direct bearing on operating results include, but are not
limited to, acceptance of our services, our ability to expand our
customer base, our ability to raise capital in the future, the
retention of key employees and changes in the regulation of our
industry.  There may be other risks and circumstances that we are
unable to predict.  When used in this Quarterly Report, words
such as,  "believes,"  "expects,"  "intends,"  "plans,"
"anticipates,"  "estimates" and similar expressions are intended
to identify forward-looking statements, although there may be
certain forward-looking statements not accompanied by such
expressions.

General

     The company is still in the development stage and is only
now beginning commercial delivery of its products and services.
In the quarter ended September 30, 2003 the company booked its
first revenues as a direct result of the implementation of its
proprietary technologies and products.

     Our principal products are: an E-Health handheld information
appliance (PDA) software application package, and a permanently
affixed handheld information appliance and Wi-Fi (wireless)
network designed for the hotel, motel and apartment marketplace.
The company has applied for and received provisional approval for
a family of trademarks making use of the mark MD@. The
provisional approval applies to the first six individual marks
applied for by the company. In addition, the company is in the
process of applying for marks associated with its ResidenceWare
hotel/motel products and technologies.

     We presently have a comprehensive suite of medical
information technology, cooperative advertising, instant
messaging and fulfillment, and electronic commerce applications
that are Internet enhanced, integrated for medical professional
use, and hotel management/guest use, both software suites
functioning through networks of wireless PDA Internet appliances.
The company's applications have been designed to meet the needs
of the inpatient and outpatient medical environments, and the
hotel management and guest (consumer), and are not just
commercially viable but also regulatory standard compliant.
Additionally, our software applications were conceived and
implemented to offer the management level user, either the
medical professional or hotel manager, the ability to manage
prospective and retrospective commerce.  The company has filed
two broad based patent applications and intends to file
derivative patent applications covering the processes, use and
functionality of its technologies and products.

     Our software is designed to integrate point of service
applications.  The medical appliance, the longest available
product, monitors treatment protocols and up to the moment
patient histories coupled with real-time on-line medical
insurance claims submission.  Our ultimate key to success resides
in providing the private practice physician with the capability
to, sequentially, learn about the history of his or her patient
during, or prior to, entering the examining room, treat the
patient and update the insurer of the episode of care.
Accomplishing these objectives resolves a major dilemma for the
health care provider; instantaneous communication of vital
patient related information at or before the patient encounter.


/11/


     The Wi-Fi hotel/motel and apartment software makes use of
much of the foundation technologies resident in the medical
product, however, given the differences in the two markets that
the products service, the hotel/motel product is much more
cooperative oriented, offering more consumer transactional
services with the compliment of advertising.

     Our medical technologies, the focus of one of the broad
based patent applications now in the patent prosecution stage,
are grounded in the central need to furnish the doctor with
crucial point-of-care patient information rapidly and reliably
via a PDA.  The technologies utilize the power of the Internet to
move large amounts of data to and from a variety of platforms
securely via a powerful Windows CE based PDA designed for
portability and upgradability.  Totally compliant with the Health
Insurance Portability and Accountability Act of 1996 ("HIPAA"),
this PDA technology is among the first to offer complicated and
real-time point of care applications, previously legacy
(mainframe or PC network) system applications, on a totally
portable (PDA) appliance.

     Our technologies and products for the hotel/motel
marketplace are designed to furnish hotel and motel guests with a
menu of food service, office services and other remote service
(dry cleaning for instance) choices that can be electronically
ordered through the company's PDA-based information appliance for
delivery directly to the hotel/motel guest.   Employing the
latest in commercial Wi-Fi technology, the company wraps the time
and volume tested commercial technologies into the company's
patent pending PDA communication networking technologies,
allowing the company to be the first to offer complex and real-
time point of sale applications through a totally wireless (PDA)
appliance.

     Our PDA software operates on any Microsoft Windows CE
"Pocket PC" based handheld device, either in a wireless or
"wired" mode.  The local host for our PDA devices is a Windows
(9X, NT or later) based PC in the physician's office, which, in
turn, permits one to eight of the aforementioned PDAs to be
linked to either a medical network or hotel/motel wide area
network, and allows each PDA to become a uniquely identified
mobile node on that network, independent of PC linkage, thereby,
assisting the professional in the review of relevant histories,
transactions, and for the medical related product --medications
and prescriptions, lab test ordering, medical step processes and
protocols and specialist referral processes.

     The PDA software provides rules based software capabilities
and the ability to receive order fulfillment information for over
5,000 users simultaneously, which represents approximately 3
years of user encounters in a typical network setting, and allows
medical professionals to access payor and health plan business
rules, and policy/plan coverage's directly from the plan(s).

     In May 2003 the company entered into an agreement with
PCHertz.com, Inc. of Fargo, ND for the distribution of and
servicing of their products and services for the hotel/motel
industry.  The agreement with PCHertz.com, Inc. has resulted in a
series of orders for the company's hotel/motel products and
services from five hotel groups, owners of hotels and motels in
the states of California, Arizona, Illinois, Iowa, South Dakota,
North Dakota, Minnesota, Virginia, and Georgia.  Initial
placement of product, now in the process of early implementation
under these agreements, will total at least 1450 of the company's
ResidenceWare units.

     On September 23, 2003 we signed a Preliminary Agreement to
Merge with MDU Services Inc. ("MDUS"), a Texas-based provider of
private digital utility services to multiple tenant residential
and business building sites, hotels/motels and universities.  The
Preliminary Agreement to merge specifies how CareDecision and
MDUS desire to execute a "triangle" merger agreement whereby
CareDecision shall acquire MDUS and then merge MDUS into a
subsidiary corporation, MDU Media Corporation (the "Merger Sub").
As of the date of this filing we are working on a definitive
agreement.


/12/


Results of Operations

     The following is an itemization of our results of operations
for the nine-month period ended September 30, 2003 in comparison
to our results of operations for the period ended September 30,
2002.

REVENUES. Total revenues for the nine-month period ended
September 30, 2003 were $24,698 as compared to total revenues of
$1,555 for the nine-month period ended September 30, 2002.  As a
development stage company we have yet to generate significant
revenues and we cannot guarantee with certainty when we will
begin to generate significant revenues.  Our future revenues will
be reliant on the acceptance of our software systems,
communication tools and suite of software applications.

GENERAL AND ADMINISTRATIVE. General and Administrative expenses
relate to the operation and leasing costs of our corporate
office.  General and administrative expenses for the nine-month
period ended September 30, 2003 were $119,545 compared to
$751,323 for the nine-month period ended September 30, 2002.
General and Administrative expenses decreased by approximately
84% from the comparable period as the Company consolidated
operations after its merger in 2002.  The company, in
anticipation of its merger made purchases of equipment and other
office related supplies in conjunction with the start of initial
business operations in the nine-month period ended September 30,
2002.

PAYROLL. Payroll expense consists primarily of management and
employee salaries.  Total payroll expense for the nine-month
period ended September 30, 2003 was $171,209.  The Company
incurred no payroll expense for the nine-month period ended
September 30, 2002.

PROFESSIONAL FEES. Professional fees include fees paid to our
accountants and attorneys.  Our professional fees were $54,693
for the nine-month period ended September 30, 2003.  The Company
incurred no professional fees for the nine-month period ended
September 30, 2002.

CONSULTING. Consulting expense includes fees paid to consultants
in relation to the preparation of required SEC filings, and to
individuals engaged to assist management in the furtherance of
our business plan.  Consulting expenses for the nine-month period
ended September 30, 2003 were $508,750 compared to $276,056 for
the nine-month period ended September 30, 2002.  Consulting
expense increased by approximately 84% from the comparable period
as the Company has engaged the services of additional consultants
to assist in the furtherance of our business model.

SOFTWARE DEVELOPMENT. Software Development expense was minimal as
our software systems; communication tools and suite of software
applications are complete.  Software Development expense for the
nine-month period ended September 30, 2003 was $3,950.  The
Company incurred no software development expense for the nine-
month period ended September 30, 2002.

DEPRECIATION. Depreciation was $246,274 for the nine-month period
ended September 30, 2003 compared to $80,383 for the nine-month
period ended September 30, 2002.  This represents depreciation on
the assets of the Company.  Depreciation expense has increased
significantly from the comparable period due to the assets
purchased in the nine-month period ended September 30, 2002,
which are now on depreciation schedules.

TOTAL OPERATING EXPENSES. Total operating expenses for the nine-
month period ended September 30, 2003 were $1,104,421 compared to
$1,107,762 for the nine-month period ended September 30, 2002.
Total operating expenses were almost unchanged from the previous
period due mainly to an increase in consulting expense and
depreciation offset by a decrease in general and administrative
expenses.  Our most significant operating expenses are consulting
and depreciation expenses.


/13/


LOSS ON DEBT SETTLEMENT. In the nine-month period ended September
30, 2003 the Company retired past debts valued at $62,094 as
compared to retired past debts of $68,363 for the nine-month
period ended September 30, 2002.  We will continue to retire our
outstanding debt as revenue allows.

INTEREST INCOME. Interest income was $561 for the nine-month
period ended September 30, 2003 compared to $2,852 for the nine-
month period ended September 30, 2002.

INTEREST EXPENSE. Interest expense was $35,558 for the nine-month
period ended September 30, 2003 compared to $22,650 for the nine-
month period ended September 30, 2002.  Interest expense
increased by approximately 57% as a result of the receipt of
loans totaling $130,606 in the nine-month period ended September
30, 2003 that bear an interest rate of 9%.

LOSS FROM OPERATIONS/NET LOSS. Our loss from operations was
$1,176,814 for the nine-month period ended March 31, 2003
compared to $1,194,368 for the nine-month period ended September
30, 2002.  It should be expected that we will continue to incur
losses from operations until such time as revenues can be
generated to cover such costs.

Future Business

     The elements of our future business strategy include:
expanding geographically into key markets through a combination
of opening new offices and developing relationships with clients
to generate demand for our services, particularly for the
company's hotel/motel and apartment products; recruiting
qualified, medical software and other technical personnel to
perform technical, implementation and support duties as contracts
are entered into, although there can be no assurance that any
such contracts will be secured; and pursuing entry into new
markets complementary to our proposed operations.  Future
operations are dependent upon our ability to implement our
business and marketing strategies and to establish relationships
and contracts with health insurers and HMOs to provide our e-
healthcare products and services, and to establish relationships
with large hotel and/or motel chains for our hotel/motel
products.

Liquidity and Capital Resources

     Management believes our cash on hand of $44,347 will not be
sufficient to fund ongoing fiscal 2003 and 2004 operations and
provide for our working capital needs given we have negative
working capital of $552,260.  Thus we will from time to time need
to raise additional funds through capital markets.  Our
accountant has issued a note concerning our ability to continue
as a going concern.  As we are still considered to be in the
development stage, our prospects of continuing as a going concern
are contingent upon our ability to raise additional capital and
to achieve and maintain profitable operations.  Revenues
generated over and above expenses will be used for further
development of our services, to provide financing for marketing
and promotion, to secure additional customers, equipment and
personnel, and for other working capital purposes.

     To date, we have financed our cash flow requirements through
an issuance of common stock and through the issuance of notes.
During the nine months ended September 30, 2003, we received
loans totaling $130,606 from a Company shareholder and director.

     During our normal course of business, we will experience net
negative cash flows from operations, pending receipt of revenues.
Further, we will be obtaining financing to fund operations
through additional common stock offerings, note issuances and
bank borrowings, to the extent available, or to obtain additional
financing to the extent necessary to augment our available cash
on hand.

     All investor inquiries should be directed via mail to Mr.
Robert Cox, President, CareDecision Corporation, 2660 Townsgate
Road, Suite 300, Westlake Village, California 91361.


/14/


                   PART II - OTHER INFORMATION

     Item 1 - Legal Proceedings

     In January 2003 M&E Equities, LLC ("M&E") and Blimie
Mendlowitz (the "plaintiffs") filed a complaint against
CareDecision Corporation, Medicius, Inc., Keith Berman, and
William Lyons (the "defendants") for failure to repay note
principal and interest and failure to deliver common stock
warrants pursuant to the terms of a Senior Convertible Note
Subscription Agreement and a Senior Convertible Promissory Note
Agreement issued to the plaintiffs.

     Specifics regarding the case are as follows:

       Case Name:    M&E Equities, LLC, and Blimie Mendlowitz,
                     against CareDecision Corporation, Medicius,
                     Inc., Keith Berman, and William Lyons.

       Court:        Supreme Court of The State of New York
                     County of New York.

       Case Number:  600092-03

     In June 2003 all parties executed a Settlement Agreement.
The Company believes that the terms of the settlement have been
fully satisfied, and has been notified by Plaintiffs that the
litigation has ended, but as of November 10, 2003 had not
received a court executed dismissal.


     Item 6(a) - Exhibits

  Exhibit  Name and/or Identification of Exhibit
  Number

   3.1    Articles of Incorporation & By-Laws
            (a) Articles of Incorporation of the Company
            filed March 2, 2001.  Incorporated by reference
            to the exhibits to the Company's General Form For
            Registration Of Securities Of Small Business
            Issuers on Form 10-SB, previously filed with the
            Commission.

            (b) Certificate of Amendment to the Articles of
            Incorporation of the Company filed May 9, 2001.
            Incorporated by reference to the exhibits to the
            Company's General Form For Registration Of
            Securities Of Small Business Issuers on Form 10-
            SB, previously filed with the Commission.

            (c) Certificate of Amendment to the Articles of
            Incorporation of the Company filed August 2,
            2002.  Incorporated by reference to the exhibits
            to the Company's June 30, 2002 Quarterly Report
            on Form 10-QSB, previously filed with the
            Commission.

   3.2      By-Laws of the Company adopted March 16, 2001.
            Incorporated by reference to the exhibits to the
            Company's General Form For Registration Of
            Securities Of Small Business Issuers on Form
            10-SB, previously filed with the Commission.

  31        Rule 13a-14(a)/15d-14(a) Certification

  32        Certification under Section 906 of the Sarbanes-
            Oxley Act (SECTION 1350)


/15/


     Item 6(b) - Reports Filed on Form 8-K

     For the quarter ended September 30, 2003 the Company filed a
report on Form 8-K with the Securities and Exchange Commission on
July 11, 2003.  The Company announced, under Item 5. Other
Events, an eight percent (8%) dividend payable in common stock.
The shares, which are restricted securities, were distributed on
or before October 15, 2003, to shareholders of record as of July
21, 2003.  In the computation of the eight percent (8%)
restricted common stock dividend, any fractional remainder was
rounded up to the nearest whole share.  The Company requested
that each shareholder turn in their certificate(s) in exchange
for a new certificate(s) on or prior to September 30, 2003 to
receive the dividend, although this was not mandatory to receive
the dividend.  Further, on July 1, 2003, the Company changed its
address.  The Company's new address is 2660 Townsgate Road, Suite
300, Westlake Village, CA 91361.  The Company's new phone number
is (805) 446-1973 and new fax number is (805) 446-1983.  No
financial statements were included in this report.



         [balance of this page intentionally left blank]


/16/


                           SIGNATURES

Pursuant to the requirements of the Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf
by the undersigned, thereunto duly authorized.

                    CareDecision Corporation
-----------------------------------------------------------------
                          (Registrant)




Date: November 12, 2003
      -----------------



By: /s/ Robert Cox
    --------------
    Robert Cox
    President and CEO





Date: November 12, 2003
      -----------------



By: /s/ Keith Berman
    ----------------
    Keith Berman
    Secretary and Treasurer/CFO


/17/